CorestemChemon (KOSDAQ: 166480) is entering a critical late-stage phase in the commercialization of its ALS stem cell therapy, Neuronata-R.
Cognizant (Nasdaq: CTSH) today announced a strategic collaboration with Bupa Hong Kong, a leading health insurance specialist in Hong Kong ...
Uniform Advantage, in partnership with the American Association of Colleges of Nursing, has announced the 2025 recipients of the Uniform Advantage–GNSA Scholarship, an annual program supporting ...
Cura Mind and Wellness announces the launch of its new telepsychiatry practice, offering holistic, integrative treatment plans that combine evidence-based interventions for mental health conditions ...
New guidance highlights evolving surgical procedure applications of reticulated open cell foam (ROCF) dressings to support patient safety, surgical outcomes and future standards of care Solventum™ ...
U.S. FDA Approval of RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) Enables the Simplest, Shortest Administration Time for a First-Line Combination Regimen when Combined with LAZCLUZE® ...
ALZpath, Inc. , a leading developer of innovative diagnostic tools for Alzheimer's and related diseases, today announced that the Simoa® ALZpath pTau217 Assay was used in a landmark ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback